Pomalidomide 4'-PEG2-acid

CAS : 2140807-17-4

Ref. 3D-QKD80717

Informations sur le produit

• Nom: Pomalidomide 4'-PEG2-acid

Description

Pomalidomide 4'-PEG2-acid is a unique compound that combines the therapeutic benefits of pomalidomide with the versatility of PEGylation. This heterobifunctional PEG (polyethylene glycol) derivative consists of an amido PEG and an acid PEG, which are linked to pomalidomide.

PEGylation is a process that involves attaching PEG molecules to a drug or therapeutic agent, enhancing its stability, solubility, and pharmacokinetic properties. In the case of Pomalidomide 4'-PEG2-acid, the PEG linker provides additional benefits such as increased water solubility and improved bioavailability.

By incorporating PEGylation into the structure of pomalidomide, Pomalidomide 4'-PEG2-acid offers enhanced drug delivery and prolonged circulation time in the body. This can result in improved efficacy and reduced dosing frequency for patients.

Furthermore, Pomalid

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 433.4 g/mol
• Formule: C₂₀H₂₃N₃O₈
• Degré de pureté: Min. 95%